Filter
3639
Filtered Results: 3639
Text search:
drug
supply
Featured
Recommendations
348
New Publications
1098
Language
Document type
No document type
2206
Studies & Reports
535
Guidelines
485
Manuals
164
Strategic & Response Plan
128
Training Material
46
Fact sheets
42
Situation Updates
17
Infographics
7
Resource Platforms
5
Brochures
2
App
1
Online Courses
1
Countries / Regions
India
248
Kenya
116
Global
108
Ethiopia
106
Uganda
101
South Africa
89
Nigeria
81
Tanzania
76
Western and Central Europe
75
Nepal
71
Malawi
69
Sierra Leone
68
Liberia
66
Myanmar / Burma
60
Zambia
58
Ghana
55
Bangladesh
53
Africa
47
Rwanda
37
Ukraine
36
Eastern Europe
36
Philippines
34
Namibia
34
Zimbabwe
32
Latin America and the Carribbean
32
Asia
29
Cambodia
28
Lesotho
26
Russia
26
South–East Asia Region
25
Botswana
22
Syria
20
Indonesia
20
Senegal
16
Mozambique
15
Congo, Democratic Republic of
15
Burkina Faso
14
East and Southern Africa
13
Middle East and North Africa
11
South Sudan
11
Eswatini/ Swaziland
11
Germany
10
Eastern Europe and Central Asia
10
Brazil
10
Georgia
10
Cameroon
9
Haiti
9
West and Central Africa
9
Albania
8
Venezuela
8
Pakistan
8
Tajikistan
7
Colombia
7
Thailand
7
Guinea
7
Vietnam
7
Sudan
7
Afghanistan
6
Western Pacific Region
6
North Macedonia
5
Benin
5
Laos
5
USA
5
Moldova
5
Argentina
4
Lebanon
4
Sri Lanka
4
Yemen
4
Iraq
4
Timor Leste/ East Timor
3
Turkey
3
China
3
Kyrgyzstan
3
Peru
3
Armenia
3
Jordan
3
Paraguay
3
North America
3
Jamaica
3
United Kingdom
3
Bhutan
3
Madagascar
3
Mexico
2
Canada
2
Fiji
2
Estonia
2
Morocco
2
Hungary
2
Saudi Arabia
2
Portugal
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Angola
2
Libya
2
Somalia
2
North Korea
1
El Salvador
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Singapore
1
Uzbekistan
1
Bulgaria
1
Guinea-Bissau
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Bolivia
1
Greece
1
Palestine
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1582
Clinical Guidelines
331
Public Health
173
Women & Child Health
140
Key Resources
122
Pharmacy & Technologies
61
Capacity Building
46
Annual Report MEDBOX
1
Toolboxes
HIV
385
TB
325
Mental Health
230
AMR
183
COVID-19
175
Pharmacy
149
NTDs
141
Caregiver
80
NCDs
69
Rapid Response
59
Ebola & Marburg
56
Planetary Health
53
Conflict
52
Global Health Education
37
Refugee
33
Health Financing Toolbox
24
Disability
23
Natural Hazards
17
Polio
17
Cholera
15
Specific Hazards
12
Malaria
11
Social Ethics
7
Zika
6
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
This document introduces four strategic objectives and twelve operational principles for good pharmaceutical procurement. These objectives and principles have been developed and endorsed by the Interagency Pharmaceutical Coordination Group (IPC), involving the pharmaceutical advisers of the United ...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
